Confluent, Inc. CFLT 深 滬
已收盤 12-12 16:00:00 美东时间
30.05
-0.090
-0.30%
華盛通- 最 高30.13
- 今 開30.10
- 成交量 1214.49万股
- 最 低 30.02
- 昨 收 30.14
- 總市值 103.67亿
- 52周最高 37.90
- 市盈率 靜 --
- 換手率 3.52%
- 52周最低 15.64
- 委 比 69.85%
- 總股本 3.45亿
- 歷史最高 94.97
- 量 比 0.23
- 振 幅 0.36%
- 歷史最低 14.69
- 每 手 1
- 風險率 4.20%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多Confluent Acquisition ‘Fuels IBM’s Strategy,’ Says Analyst
International Business Machines ($IBM) has been one of 2025’s standout performe...
12-12 05:45
Workato Forms Technology Partnership With Confluent To Integrate Streaming Agents With Enterprise MCP For Real‑Time Signal Detection & Orchestration
New Integration Connects Confluent Streaming Agents with Workato Enterprise MCP to Close the Gap Between Signal Detection and Business ExecutionWorkato®, the Enterprise MCP company, today announced a technology
12-12 02:04
IBM, Toast, AppLovin And An Industrial Stock On CNBC's 'Final Trades'
Stephanie Link loves IBM's acquisition of Confluent for $11B, Joshua Brown picked Toast, JP Morgan upgraded Toast, Brian Belski chose TopBuild, and Joseph M. Terranova has high hopes for AppLovin's all-time high.
12-10 20:51
Guggenheim Downgrades Confluent to Neutral
Guggenheim analyst Howard Ma downgrades Confluent (NASDAQ:CFLT) from Buy to Neutral.
12-10 19:49
美股大行评级 | 花旗上调苹果目标价升至330美元；GPCR、KYMR、MAMA、TERN、WVE等获多家机构上调目标价
今日重点评级关注：Chardan Capital：维持Senti Biosciences"买入"评级，目标价从12美元升至13美元；Guggenheim：维持Praxis Precision Medicine"买入"评级，目标价从540美元升至760美元
12-10 10:33
Oppenheimer Downgrades Confluent to Perform
Oppenheimer analyst Ittai Kidron downgrades Confluent (NASDAQ:CFLT) from Outperform to Perform.
12-10 01:30
美股异动 | 黄金白银股集体走强！泛美白银涨超5%，赫克拉矿业大涨超4%
白银逼近历史高位，现货黄金站上4200美元！黄金白银股集体走强，泛美白银大涨超5%，赫克拉矿业涨超4%，哈莫尼黄金、纽曼矿业涨超2%>>
12-09 23:10
华尔街顶级分析师最新评级：新思科技获上调、华纳兄弟遭下调
华尔街最受热议且对市场影响显著的研报评级观点现已汇总于此。以下是由 The Fly 整理的、投资者今日需关注的研报评级变动信息。 五大评级上调 新思科技...
12-09 23:09
RBC Capital Downgrades Confluent to Sector Perform, Raises Price Target to $31
RBC Capital analyst Matthew Hedberg downgrades Confluent (NASDAQ:CFLT) from Outperform to Sector Perform and raises the price target from $30 to $31.
12-09 20:02
Needham Downgrades Confluent to Hold
Needham analyst Mike Cikos downgrades Confluent (NASDAQ:CFLT) from Buy to Hold.
12-09 18:28
